United States Pharmaceuticals

Midatech Pharma US Inc (POTP)

Track

Ticker: POTP
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
CLEMENT CHRISTOPHER G President Executive Director
Transaction date
Purchase
Price
487.52
Quantity 17,535 +43.2%
Value US$1,711,272
COCHRANE HAYWOOD D Non-Executive Director
Transaction date
Purchase
Price
359.18
Quantity 13,786 -39.3%
Value US$636,079
Heady Timothy James Non-Executive Director
Transaction date
Purchase
Price
214.69
Quantity 42,747 -24.7%
Value US$3,596,946
Drutz David CEO and CMO Executive Director
Transaction date
Purchase
Price
0.70
Quantity 25,000 +32.0%
Value US$17,440
Drutz David CEO and CMO Executive Director
Transaction date
Purchase
Price
1.06
Quantity 25,000 +47.1%
Value US$26,500
COCHRANE HAYWOOD D Non-Executive Director
Transaction date
Purchase
Price
0.82
Quantity 2,800 +18.3%
Value US$2,296
COCHRANE HAYWOOD D Non-Executive Director
Transaction date
Purchase
Price
0.78
Quantity 2,200 +16.8%
Value US$1,716
COCHRANE HAYWOOD D Non-Executive Director
Transaction date
Purchase
Price
0.73
Quantity 9,000 +221.0%
Value US$6,580
COCHRANE HAYWOOD D Non-Executive Director
Transaction date
Purchase
Price
0.75
Quantity 1,000 +32.5%
Value US$745
Drutz David CEO and CMO Executive Director
Transaction date
Purchase
Price
0.77
Quantity 25,000 +89.1%
Value US$19,250
Drutz David CEO and CMO Executive Director
Transaction date
Purchase
Price
0.90
Quantity 25,000 +813.5%
Value US$22,532
FRANCO RICHARD A President & CEO Executive Director
Transaction date
Purchase
Price
2.78
Quantity 3,500 +2.1%
Value US$9,730
FRANCO RICHARD A President & CEO Executive Director
Transaction date
Purchase
Price
2.64
Quantity 5,000 +4.6%
Value US$13,200
FRANCO RICHARD A President & CEO Executive Director
Transaction date
Purchase
Price
2.29
Quantity 5,000 +4.9%
Value US$11,450
Didsbury John Chief Scientific Officer Officer
Transaction date
Purchase
Price
2.47
Quantity 4,600 +inf%
Value US$11,362
Didsbury John Chief Scientific Officer Officer
Transaction date
Purchase
Price
2.20
Quantity 4,400 +inf%
Value US$9,696
FRANCO RICHARD A Chairman, President and CEO Executive Director
Transaction date
Purchase
Price
1.90
Quantity 10,200 +inf%
Value US$19,380
BARBERICH TIMOTHY J Non-Executive Director
Transaction date
Purchase
Price
3.00
Quantity 34,500 +inf%
Value US$103,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-06-04 2013-06-03 B Purchase CLEMENT CHRISTOPHER G

President

Executive Director
17,535 +43.2%
487.52
US$1,711,272 		17,535 +43.2% 487.52 US$1,711,272
2013-05-31 2013-05-30 B Purchase COCHRANE HAYWOOD D Non-Executive Director
13,786 -39.3%
359.18
US$636,079 		13,786 -39.3% 359.18 US$636,079
2013-05-24 2013-05-23 B Purchase Heady Timothy James Non-Executive Director
42,747 -24.7%
214.69
US$3,596,946 		42,747 -24.7% 214.69 US$3,596,946
2013-05-20 2013-05-17 B Purchase Drutz David

CEO and CMO

Executive Director
25,000 +32.0%
0.70
US$17,440 		25,000 +32.0% 0.70 US$17,440
2012-09-17 2012-09-17 B Purchase Drutz David

CEO and CMO

Executive Director
25,000 +47.1%
1.06
US$26,500 		25,000 +47.1% 1.06 US$26,500
2012-09-12 2012-09-11 B Purchase COCHRANE HAYWOOD D Non-Executive Director
2,800 +18.3%
0.82
US$2,296 		2,800 +18.3% 0.82 US$2,296
2012-09-12 2012-09-10 B Purchase COCHRANE HAYWOOD D Non-Executive Director
2,200 +16.8%
0.78
US$1,716 		2,200 +16.8% 0.78 US$1,716
2012-07-23 2012-07-20 B Purchase COCHRANE HAYWOOD D Non-Executive Director
9,000 +221.0%
0.73
US$6,580 		9,000 +221.0% 0.73 US$6,580
2012-07-23 2012-07-19 B Purchase COCHRANE HAYWOOD D Non-Executive Director
1,000 +32.5%
0.75
US$745 		1,000 +32.5% 0.75 US$745
2012-06-11 2012-06-08 B Purchase Drutz David

CEO and CMO

Executive Director
25,000 +89.1%
0.77
US$19,250 		25,000 +89.1% 0.77 US$19,250
2012-05-30 2012-05-29 B Purchase Drutz David

CEO and CMO

Executive Director
25,000 +813.5%
0.90
US$22,532 		25,000 +813.5% 0.90 US$22,532
2011-04-26 2011-04-26 B Purchase FRANCO RICHARD A

President & CEO

Executive Director
3,500 +2.1%
2.78
US$9,730 		3,500 +2.1% 2.78 US$9,730
2010-09-03 2010-09-02 B Purchase FRANCO RICHARD A

President & CEO

Executive Director
5,000 +4.6%
2.64
US$13,200 		5,000 +4.6% 2.64 US$13,200
2010-08-31 2010-08-31 B Purchase FRANCO RICHARD A

President & CEO

Executive Director
5,000 +4.9%
2.29
US$11,450 		5,000 +4.9% 2.29 US$11,450
2008-02-25 2008-02-22 B Purchase Didsbury John

Chief Scientific Officer

Officer
4,600 +inf%
2.47
US$11,362 		4,600 +inf% 2.47 US$11,362
2008-02-25 2008-02-22 B Purchase Didsbury John

Chief Scientific Officer

Officer
4,400 +inf%
2.20
US$9,696 		4,400 +inf% 2.20 US$9,696
2008-02-25 2008-02-22 B Purchase FRANCO RICHARD A

Chairman, President and CEO

Executive Director
10,200 +inf%
1.90
US$19,380 		10,200 +inf% 1.90 US$19,380
2005-11-22 2005-11-21 B Purchase BARBERICH TIMOTHY J Non-Executive Director
34,500 +inf%
3.00
US$103,500 		34,500 +inf% 3.00 US$103,500
Explore more

More insider trading research around Midatech Pharma US Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America